It’ll be awhile before Viscardi Andrade can step back inside the Octagon.
The Ultimate Fighting Championship (UFC) welterweight was last seen in action back in March 2016. He earned a unanimous decision over Richard Walsh. Andrade was flagged by the U.S. Anti-Doping Agency (USADA) for a violation of its policy. The 170-pounder tested positive for an Anabolic Agent on March 7, 2016.
Andrade’s two-year suspension was in effect a day after his bout with Walsh. As a result, he can make his return to professional mixed martial arts (MMA) competition in 2018.
USADA released a statement regarding Andrade’s period of ineligibility. You can read part of it below:
”Andrade, 33, tested positive for stanozolol and its metabolites, 16β‐hydroxy‐stanozolol and 3’‐hydroxy‐stanozolol, following an out-of-competition urine test conducted on March 7, 2016. Stanozolol is a non-Specified Substance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
Andrade’s two-year period of ineligibility began on March 20, 2016, the day after his most recent bout, a victory, at the UFC Fight Night event in Brisbane, Australia, on March 19, 2016. Per the UFC Anti-Doping Policy, an Anti-Doping Policy Violation occurring during, or in connection with, a bout may, upon the decision of UFC, lead to disqualification of all the athlete’s results obtained in that bout. Here, because Andrade’s violation resulted from a sample collection that occurred prior to his bout, all information surrounding Andrade’s positive test and sanction has been provided to UFC to make the determination concerning his competition results.”
